Veraxa Biotech AG - Post de-SPAC (VRXA) insider trading
Every open-market stock purchase and sale by Veraxa Biotech AG - Post de-SPAC executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Christoph Samuel Ziegler (Director) and 1 other bought $42.8K in the last 90 days, more than doubling their stake.
Last 12 months: insiders bought $42.8K (2 buys) and sold $0 (0 sales). Last close $1.06 on Oct 21, 2026.
Recent VRXA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 20, 2026 | Christoph Samuel Ziegler (Director) | Bought | $32.7K |
| Sep 10, 2026 | Warren Hosseinion (Director) | Bought | $10.1K |
Who's trading VRXA
- Christoph Samuel Ziegler, Director: bought $32.7K (1 buy), last Oct 20, 2026
- Warren Hosseinion, Director: bought $10.1K (1 buy), last Sep 10, 2026
Get free alerts when an insider at Veraxa Biotech AG - Post de-SPAC files a new trade →